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Age (years) ± SD 69.6 ± 10.6 61.5 ± 11,8 <0.0001 
Male sex % (n) 71.4% (20) 78.9% (418) NS 
CV risk factors % (n) 
  Diabetes Mellitus 
  Hypertension 













Previous renal insufficiency % (n) 42.9% (12) 14.9% (71) <0.0001 
CV history % (n) 
  Previous AMI 
  Previous angor 
  Previous PCI 
  Previous CABG 
  Peripheral arterial disease 























  Heart rate (bpm) ± SD 
  SAP (mmHg) ± SD 
  KK> 1 % (n) 
 
85 ± 22 
153 ± 29 
42.9% (12) 
 
75 ± 18 






Of the 558 patients reviewed, 5% (n=28) developed CIN.  
Contrast-induced nephropathy (CIN) is a form of hospital-acquired acute renal failure that sometimes develops after giving iodinated radiocontrast agents. The growing number of patients who undergo coronary angiography and 
percutaneous revascularization after acute coronary syndrome (ACS) brought more relevance to this entity. It’s actually one of the most frequent forms of hospital-acquired acute renal failure. The purpose of this study was to define the 
predictors and prognostic value of CIN in a population of patients admitted with ACS.  
A total of 558 patients consecutively admitted with ACS and submitted to cardiac catheterization procedure, from January 2004 to April 2006, were reviewed. CIN was defined as impairment of renal function occurring within 48 hours after 
administration of contrast media and manifested by an absolute increase in the serum creatinine level of at least 0.5 mg/dL or by a relative increase of at least 25% over the baseline value (in the absence of another cause). The patients 






STEMI % (n) 32.1% (9) 44% (233) NS 
Reperfusion therapy % (n) 28.6% (8) 25.7% (136) NS 
In-hospital medical therapy % (n) 
  ASA 
  Clopidogrel 
  ASA + Clopidogrel 
  LMWH 
  UFH 
  Ace inhibitor 
  β-blocker 
  Statin 
  Nitrates 


































LVEF <50% 85.7% (24) 62.6% (332) 0.006 
PCI % (n) 46.4% (13) 43.2% (229) NS 
Surgical revascularization % (n) 28.5% (8) 14.7% (78) NS 
Presentation and in-hospital medical treatment 


















Covariates considered in the 
model: renal insufficiency, Killip 
class >1 at admission, heart rate at 
admission, systolic arterial 
pressure at admission and left 
ventricular ejection fraction <50% 
